~~<i id='0C327F96CE'><strike id='0C327F96CE'><tt id='0C327F96CE'><pre id='0C327F96CE'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

explore

author：knowledge 2025-08-03 03:30:57 - browse：838

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Wellcome Trust names Røttingen as its new CEO

leisure time

Wikipedia

focus

explore

entertainment

Wikipedia

APStockYou’rereadingthewebeditionofSTAT’sHealthTechnewsletter,ourguidetohowtechnologyistransformingt

WSS

Akero's treatment for NASH falls short in cirrhosis study

Diagnostic tests are hitting their mathematical limits

How clinical AI models' predictive power can degrade over time

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

With clinical trial data readouts, here's how to spot spin

What the Wegovy shortage looks like for doctors — and for patients

hotspot

explore

leisure time

Wildfire smoke exposes gaps in outdoor worker protections

As biotech industry slumps, bioscience job market is upside down

Virginia high school admissions case could be legal follow

BIO selects John Crowley as new CEO

United colonoscopy coverage change 'may cost lives,' doctors say

Medicare to cover more brain scans related to Alzheimer’s drugs

The high cost of giving birth even with insurance

Flagship Pioneering launches a new biotech in two countries

In Memoriam: Notable people who died in 2023

Better Therapeutics data on benefit with GLP

Wikipedia

Will the market for weight loss drugs really reach $100 billion?

What don’t we know about an Alzheimer’s drug side effect?

Cancer cells are shown to suck energy source from immune cells

Akero's treatment for NASH falls short in cirrhosis study

Eight reasons why you should get an updated Covid vaccine

FDA investigates CAR

focus

explore

entertainment

Wikipedia